TG Therapeutics Inc Cash Flow Quality Index
TG Therapeutics Inc cash flow quality index. TG Therapeutics Inc (TGTX) has a Cash Flow Quality Index of 0.78x as of June 2026. Operating cash flow of $21.37 Million is below net income of $27.56 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial agility of TG Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of TG Therapeutics Inc (2010–2025)
Cash flow quality index of TG Therapeutics Inc from 2010 to 2025. Historical Cash Flow Quality Index for TG Therapeutics Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore TG Therapeutics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
TG Therapeutics Inc Cash Flow Quality Index by Year (2010–2025)
TG Therapeutics Inc cash flow quality index by year from 2010 to 2025. Year-by-year earnings quality comparison for TG Therapeutics Inc. For the full cash flow conversion analysis, see cash flow conversion of TG Therapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.06x | $-24.77 Million | $447.18 Million | ▲ +96.8% |
| 2024 | -1.73x | $-40.52 Million | $23.38 Million | ▲ +30.1% |
| 2023 | -2.48x | $-31.41 Million | $12.67 Million | ▲ +21.5% |
| 2010 | -3.16x | $-1.97 Million | $623.64K | — |